Evidence map›Paper›PMID 40035055›Full record

ArticleIDCases2025

Histoplasmosis - More common than we realize.

Ujjwayini Ray, Soma Dutta, Arpita Sutradhar

Abstract read
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ujjwayini RayApollo Multispeciality Hospitals, Kolkata, India.
Soma DuttaApollo Multispeciality Hospitals, Kolkata, India.
Arpita SutradharApollo Multispeciality Hospitals, Kolkata, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histoplasmosis is primarily associated with immunocompromised individuals; however, its presentation in immunocompetent patients is increasingly recognized. This series of 5 cases from eastern India, a potential Histoplasmosis hotspot, describes five immunocompetent individuals with the disease. It emphasizes the diverse clinical spectrum of Histoplasmosis, often mimicking other conditions, thereby complicating diagnosis. Four patients presented with adrenal masses, emphasizing the importance of considering histoplasmosis in the differential diagnosis of adrenal enlargement. One patient developed hemophagocytic lymphohistiocytosis (HLH), underscoring the severe complications associated with disseminated histoplasmosis. Additionally, one patient exhibited localized disease, demonstrating the variable clinical presentations of this infection. Our findings emphasize the need for heightened clinical suspicion of histoplasmosis in patients with adrenal masses or unexplained fever, even in immunocompetent individuals in a relevant epidemiological setting. Early diagnosis and appropriate antifungal therapy are crucial for optimal outcomes.

Indexed as

Adrenal enlargementEndemicHemophagocytic lymphohistiocytosis (HLH)Histoplasma capsulatum

Identifiers

PMID40035055
PMCPMC11872629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.